Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells.

Abstract

BACKGROUND:

Bifidobacterium longum subsp. infantis (B. infantis) is a commensal bacterium that colonizes the gastrointestinal tract of breast-fed infants. B. infantis can efficiently utilize the abundant supply of oligosaccharides found in human milk (HMO) to help establish residence. We hypothesized that metabolites from B. infantis grown on HMO produce a beneficial effect on the host.

RESULTS:

In a previous study, we demonstrated that B. infantis routinely dominated the fecal microbiota of a breast fed Bangladeshi infant cohort (1). Characterization of the fecal metabolome of binned samples representing high and low B. infantis populations from this cohort revealed higher amounts of the tryptophan metabolite indole-3-lactic acid (ILA) in feces with high levels of B. infantis. Further in vitro analysis confirmed that B. infantis produced significantly greater quantities of the ILA when grown on HMO versus lactose, suggesting a growth substrate relationship to ILA production. The direct effects of ILA were assessed in a macrophage cell line and intestinal epithelial cell lines. ILA (1-10 mM) significantly attenuated lipopolysaccharide (LPS)-induced activation of NF-kB in macrophages. ILA significantly attenuated TNF-α- and LPS-induced increase in the pro-inflammatory cytokine IL-8 in intestinal epithelial cells. ILA increased mRNA expression of the aryl hydrogen receptor (AhR)-target gene CYP1A1 and nuclear factor erythroid 2-related factor 2 (Nrf2)-targeted genes glutathione reductase 2 (GPX2), superoxide dismutase 2 (SOD2), and NAD(P) H dehydrogenase (NQO1). Pretreatment with either the AhR antagonist or Nrf-2 antagonist inhibited the response of ILA on downstream effectors.

CONCLUSIONS:

These findings suggest that ILA, a predominant metabolite from B. infantis grown on HMO and elevated in infant stool high in B. infantis, and protects gut epithelial cells in culture via activation of the AhR and Nrf2 pathway.

• Authors: Amy M Ehrlich, Alline R Pacheco, Bethany M Henrick, Diana Taft, Gege Xu, M Nazmul Huda, Darya Mishchuk, Michael L Goodson, Carolyn Slupsky, Daniela Barile, Carlito B Lebrilla, Charles B Stephensen, David A Mills, Helen E Raybould
• Journal: BMC microbiology (BMC Microbiol) Vol. 20 Issue 1 Pg. 357 (11 23 2020) ISSN: 1471-2180 [Electronic] England
• PMID: 33225894 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)

Chemical References

• Anti-Inflammatory Agents
• Endotoxins
• Indoles
• Interleukin-8
• NF-E2-Related Factor 2
• Oligosaccharides
• Receptors, Aryl Hydrocarbon
• indole-3-lactic acid
• Lactose

Topics

• Animals
• Anti-Inflammatory Agents (analysis, pharmacology)
• Bifidobacterium (metabolism, physiology)
• Cell Line
• Endotoxins (pharmacology)
• Epithelial Cells (drug effects, metabolism)
• Feces (chemistry, microbiology)
• Gastrointestinal Tract (metabolism, microbiology)
• Humans
• Indoles (analysis, pharmacology)
• Infant
• Interleukin-8 (metabolism)
• Lactose (metabolism)
• Macrophage Activation (drug effects)
• Mice
• Microbiota
• Milk, Human (metabolism)
• NF-E2-Related Factor 2 (metabolism)
• Oligosaccharides (metabolism)
• Receptors, Aryl Hydrocarbon (metabolism)
• Signal Transduction (drug effects)